FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3528361015 | PCSK9 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3528362010 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3528363017 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PCSK9 inhibitor | Is a | Hydrolase inhibitor | true | Inferred relationship | Some | ||
| PCSK9 inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Proprotein convertase subtilisin/kexin type 9 inhibitor (disposition) | true | Inferred relationship | Some | ||
| PCSK9 inhibitor | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| PCSK9 inhibitor | Is a | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alirocumab (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Evolocumab (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | PCSK9 inhibitor | Inferred relationship | Some | 1 |
| Inclisiran (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Inclisiran sodium (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets